Balancing Favourable Drug-Likeness Against Respiratory and Renal Liabilities: An Integrated In Silico ADME–Toxicity Profile of a Novel 3-{[2-(Formimidoylamino)ethyl]sulfanyl}-6-(1-methoxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carbonyl fluoride. Editon Consortium Journal of Research in Medical and Health Sciences, v. 6, n. 1, p. 28–40, 12 Sep.2026.